About the journal
Blood Cancer Journal is an open-access journal published by Nature Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Publishing Group
- ISSN
- 2044-5385
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,390 EUR
- Articles in DOAJ
- 1158
- Declared review time
- 14 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/bcj/index.html
Index listings
- DOAJ · 2012-02-15
- MEDLINE · 2014-01-01
- PUBMED · 2011-03-04
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- 14 weeks
- Actual review time (measured)
- 108 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1158
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
2149
Last recorded publication year
2026
h-index
109
i10-index
1355
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2012-02-15
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 100%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101568469
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
Show all subjects (50)
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- CAR-T cell therapy research
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Kruppel-like factors research
- Kruppel-like factors research
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Retinoids in leukemia and cellular processes
- Retinoids in leukemia and cellular processes
- Monoclonal and Polyclonal Antibodies Research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Monoclonal and Polyclonal Antibodies Research
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
Keywords (DOAJ)
- hematologic malignancies
- blood cancer
- immunology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ